SPA17 anticorps (N-Term)
Aperçu rapide pour SPA17 anticorps (N-Term) (ABIN928702)
Antigène
Voir toutes SPA17 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Purification
- Purified
-
Immunogène
- SPA17 antibody was raised in rabbit using the N terminal of SPA17 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
SPA17 Blocking Peptide, (ABIN5616350), is also available for use as a blocking control in assays to test for specificity of this SPA17 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- SPA17 (Sperm Autoantigenic Protein 17 (SPA17))
-
Autre désignation
- SPA17
-
Sujet
- This gene encodes a protein present at the cell surface. The N-terminus has sequence similarity to human cAMP-dependent protein kinase A (PKA) type II alpha regulatory subunit (RIIa) while the C-terminus has an IQ calmodulin-binding motif. The central portion of the protein has carbohydrate binding motifs and likely functions in cell-cell adhesion. The protein was initially characterized by its involvement in the binding of sperm to the zona pellucida of the oocyte. Recent studies indicate that it is also involved in additional cell-cell adhesion functions such as immune cell migration and metastasis. A retrotransposed pseudogene is present on chromosome 10q22. Synonyms: Polyclonal SPA17 antibody, Anti-SPA17 antibody, sperm autoantigenic protein 17 antibody, SP17 antibody, SP17-1 antibody.
Antigène
-